SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wipro secures multi-million dollar deal from AstraZeneca

21 Dec 2011 Evaluate

Wipro, India’s third largest IT bellwether has been selected as an IT partner for a multi-million dollar engagement with AstraZeneca, a leading global biopharmaceutical company. However, the deal size was not disclosed.

The company has been selected as one of four IT partners, after a six-month evaluation period, to enhance AstraZeneca’s end user computing infrastructure.

Wipro’s net profit for the second quarter of the current fiscal declined by 10.37% at Rs 1050.6 crore as compared to Rs 1172.1 crore for the corresponding quarter  of the previous fiscal. The company’s total income increased by 19.69% at Rs 8011.5 crore for the quarter under review as compared to Rs 6693.7 crore for the second quarter of the previous year.

Wipro Share Price

197.95 0.60 (0.30%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 2394.85
Infosys 1179.20
HCL Tech. 1198.60
Wipro 197.95
Tech Mahindra 1463.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×